United States Pharmacopoeia (USP) Solutions and Reagents
United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.
Found 7624 products of "United States Pharmacopoeia (USP) Solutions and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Scopine di(2-thienylglycolate) (2-Thiopheneacetic acid, α-hydroxy-α-2-thienyl-, (1α,2β,4β,5α,7β)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0 2,4]non-7-yl ester)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NO4S2Color and Shape:White Off-White PowderMolecular weight:377.48P-Chloroaniline
CAS:Aniline derivatives and their saltsFormula:C6H6ClNColor and Shape:White Light Yellow PowderMolecular weight:127.57Metronidazole
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C6H9N3O3Color and Shape:White Pale Yellow Crystalline PowderMolecular weight:171.15Meclizine Related Compound B (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C25H27ClN2·2HCl·H2OColor and Shape:White PowderMolecular weight:390.18628Nateglinide Related Compound B (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C19H27NO3Color and Shape:White PowderMolecular weight:317.42Cinacalcet Related Compound D ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormula:C22H22F3N·HClColor and Shape:Pale Yellow PowderMolecular weight:393.14711Desbromo 4,5-Didehydro Brimonidine (N-(1H-imidazol-2-yl)quinoxalin-6-amine)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C11H9N5Color and Shape:Brown PowderMolecular weight:211.22Paeoniflorin
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesFormula:C23H28O11Color and Shape:Off-White White PowderMolecular weight:480.16316Amiloride Hydrochloride
CAS:Cardiovascular drugs, nesoiFormula:C6H8ClN7O·HCl·2H2OColor and Shape:Pale Yellow Yellow Green PowderMolecular weight:302.12Zaleplon Related Compound A ((E)-N-{3-[3-(dimethylamino)acryloyl]phenyl}-N-ethylacetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C15H20N2O2Color and Shape:Yellow PowderMolecular weight:260.15248Methimazole Related Compound A (2,2-Dimethoxy-N-methylethanamine)
CAS:Amino-alcohols, other than those containing more than oneFormula:C5H13NO2Color and Shape:Colorless Light Yellow LiquidMolecular weight:119.09463Dabigatran Etexilate Amide (Hexyl [{4-[({5-[(3-amino-3-oxopropyl)(pyridin-2-yl)carbamoyl]-1-methyl-1H-benzimidazol-2-yl}methyl)amino]phenyl}(imino)methyl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H38N8O4Color and Shape:Yellow PowderMolecular weight:598.7Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.12739Insulin Lispro
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C257H383N65O77S6Color and Shape:White Off-White Crystalline PowderMolecular weight:5803.63765Cefuroxime Axetil E-isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H22N4O10SColor and Shape:Pale Yellow PowderMolecular weight:510.10566Brinzolamide Related Compound B ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate)
CAS:Sulfonamides, nesoiFormula:C10H17N3O5S3·C2H2O4Color and Shape:Off-White SolidMolecular weight:445.49Carglumic Acid Related Compound A ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C6H8N2O4Color and Shape:White Off-White PowderMolecular weight:172.14Fexofenadine Related Compound B (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H39NO4·HCl·H2OColor and Shape:White PowderMolecular weight:555.27515
